Together, we can turn groundbreaking concepts into impactful solutions.

Partnering with government, institutions, foundations, and nonprofits, we tackle pressing health challenges efficiently through the power of collaboration. Our experienced team of experts in science, medicine, engineering, and business work alongside our partners to identify and nurture high-potential health innovation projects. 

The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Moving Ideas Forward

  • Proven Processes: Streamlined methodologies that ensure efficiency and effectiveness. 
  • Hands-On Facilitation: Direct, personalized assistance at every step of the innovation process.
  • Global Network: Access to a world-class network of experts ready to lend insights and experience.
  • Customized Tools: Tailored infrastructure, tools, and resources designed to fit the needs of your project.  

     

Where We Excel

  • Spotting highly promising projects.
  • Engaging the world’s leading experts.
  • Minimizing risk through our Deep Dive evaluation.
  • Maximizing speed and efficiency with the support of tailored tools.
  • Accelerating development through our proven process.

 

 

Our Impact

We have supported more than 1,200 innovator teams, evaluated more than 5,000 ideas, and helped develop more than a thousand health innovations. Our efforts have resulted in:

  • 49% commercialization success rate.
  • $2 billion in follow-on funding.
  • 1000+ healthcare innovations developed.
  • touching millions of lives.

 

Innovation Spotlight

Innovation Spotlight

Webinar: Monkeypox Emergence

Webinar - Monkeypox: Emergence of a Global Public Health Threat

Monkeypox has emerged as a global public health threat. Our understanding of this disease is improving, however, many questions remain. This webinar will cover what is known about the epidemiology, pathogenesis, clinical features, diagnostics, and treatment of this disease. Questions yet to be answered will be explored.

Speakers: 

Bruce Tromberg, PhD 
Director, National Institute of Biomedical Imaging and Bioengineering

Matthew M Hamill, M.B.Ch.B., Ph.D., M.P.H., M.Sc. 
Assistant Professor of Medicine
Division of Infectious Diseases at Johns Hopkins School of Medicine
Clinical Chief for STI at Baltimore City Health Department.

Yukari C. Manabe, MD, FIDSA, FRCP 
Professor of Medicine, MMI, International Health
Director, Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases
Associate Director of Global Health Research and Innovation
Johns Hopkins Center for Global Health

When: September 27, 2022 2:30 PM ET

Watch the recording >

Download the slides >